Overall, these findings underscore the complexity of the molecular interactions with the neural circuitry underlying anxiety and highlight the necessity for a multifaceted approach in the design of anxiolytic treatments
LDN is a medicine that was originally used at higher doses for different health issues, but when taken in low doses, it has been found to help with several other conditions, including weight loss
Starting a GLP-1 medication like Semaglutide or Tirzepatide can be a turning point for people who have struggled with dieting, cravings, or inconsistent weight loss
The medications mechanisms of action, including improvements in insulin sensitivity, weight loss, and hormonal regulation, make it a compelling candidate for addressing the metabolic and reproductive aspects of PCOS
In these cases, clinicians should assume a higher risk of retained gastric contents when GLP-1 exposure is known or suspected, especially if the patient has gastrointestinal symptoms
Kaufman believes that by reducing systemic inflammation, the GLP-1 agonists are getting at one of the root causes of these diseases
